| Literature DB >> 34201915 |
Avez Sharipov1, Zufar Boboev1,2, Sunnatullo Fazliev3,4, Shokhid Gulyamov1,5, Akhmatkhodja Yunuskhodjayev6, Jamoliddin Razzokov1,7,8,9,10.
Abstract
Iodine, being an intrinsic part of thyroid hormones, is a vital microelement required for normal growth and development, particularly in children. Inadequate daily intake of iodine causes iodine deficiency, which is responsible for several health disorders, such as cretinism and goiters. Therefore, the development of new drugs and/or food supplements for iodine deficiency is crucial. We synthesized an iodine/β-cyclodextrin complex based on a host-guest model, and in this paper, we outline the development of a new quantitative analysis method. We suggest a robust and reliable high-performance liquid chromatography method to determine the total amount of iodine species in the complex. Moreover, we performed validation of our method. The results of validation presented here show the reliability, accuracy and high precision of the method. Furthermore, for the first time, we show results of in vivo studies for the thyroid-stimulating activity of the iodine/β-cyclodextrin complex. Our findings indicate that the thyroid-stimulating activity of iodine/β-cyclodextrin is comparable to that of potassium iodide, which is the main active pharmaceutical substance of conventional drugs for iodine deficiency.Entities:
Keywords: iodine; iodine deficiency; iodine/β-CD; methimazole; potassium iodide; thyroid-stimulating activity; β-cyclodextrin
Year: 2021 PMID: 34201915 DOI: 10.3390/pharmaceutics13070955
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321